ANNX

Annexon, Inc.

5.60 USD
-0.27 (-4.60%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Annexon, Inc. stock is up 10.45% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 4 July’s closed higher than June. In the last 10 Unusual Options Trades, there were 10 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
13 Jun 19:11 17 Jan, 2025 3.00 CALL 300 1
10 Jul 17:32 19 Jul, 2024 2.50 CALL 150 451
10 Jul 17:41 19 Jul, 2024 2.50 CALL 173 451
11 Jul 15:17 17 Jan, 2025 3.00 CALL 250 714
11 Jul 15:27 17 Jan, 2025 3.00 CALL 150 714
11 Jul 17:51 19 Jul, 2024 5.00 CALL 400 1249
11 Jul 19:53 17 Jan, 2025 3.00 CALL 100 714
15 Jul 19:22 18 Oct, 2024 2.50 CALL 180 793
15 Jul 19:48 18 Oct, 2024 2.50 CALL 220 793
17 Jul 14:53 16 Aug, 2024 6.00 CALL 968 1073

About Annexon, Inc.

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain-baré syndrome. The company was incorporated in 2011 and is headquartered in Brisbane, California.